New Veeva Link Applications Give Clinical Teams Real-Time Intelligence to Optimize Site Selection and Trial Design

Veeva Systems announced two new Veeva Link applications to help clinical teams improve site selection and optimize trial design. Link SiteBase identifies, filters, and ranks research sites. Link TrialBase delivers clinical trial intelligence, including current status, inclusion criteria, protocol design, and endpoints.

“At Seagen, we are dedicated to revolutionizing cancer care through transformative therapies that make a meaningful difference in people’s lives,” said Kamran Ansari, head of clinical development operations at Seagen. “Gaining meaningful insights as early as possible in planning is at the core of optimizing protocol development and site identification. With Link SiteBase and Link TrialBase, Veeva is bringing much needed innovation to the clinical trial intelligence space.”

Recommended AI News: Eko Awarded $2.7 Million SBIR Grant from NIH to Develop Pulmonary Hypertension AI

Veeva Link applications are created by a modern data platform that combines intelligent software automation with human curation to ensure accuracy and depth. This allows Veeva Link to deliver real-time intelligence across a growing number of areas, including sales, marketing, market access, medical, and now clinical.

“Trial execution remains difficult due to intense competition for research sites and greater protocol complexity,” said Jim Reilly, vice president, Veeva Development Cloud strategy. “With comprehensive, high-quality data and a user-friendly experience, Link SiteBase and Link TrialBase will speed trial execution and improve trial outcomes.”

Recommended AI News: LZG International, Inc. (FatBrain AI) Announces Plans to Uplist to OTCQB Venture Market

[To share your insights with us, please write to sghosh@martechseries.com]